Oxford Nanopore Technologies promethION 2 integrated long-read sequencer
Closed Pre-Solicitation Posted
- Solicitation number
- 75N98026Q00877OXFORDNANOTECHNOLOGIESLTD
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541713 Research and Development in Nanotechnology
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of Logistics and Acquisition Operations is preparing to procure an Oxford Nanopore Technologies promethION 2 integrated long-read sequencer, with responses due August 5, 2026 at 9:00 a.m. Eastern Time. The procurement is structured as a non-competitive, sole-source award not exceeding the simplified acquisition threshold of $350,000 under FAR Part 13, though the government retains discretion to conduct competitive procurement based on responses received.
The requirement is for one promethION 2 unit, which delivers long-read sequencing with greater informativeness than standard next-generation sequencing. The equipment enables simultaneous whole genome and transcriptome sequencing with base-call modifications and supports real-time multi-omics integration capabilities not available in competing sequencing technologies. NAICS code 541713 (Research and Development in Biotechnology) applies, with PSC 6505 (Drugs and Biologicals).
Interested parties must submit technical proposal, cost-price proposal, period of performance, Unique Entity ID, Taxpayer Identification Number, and business size certification electronically to Vishnuvajjala Hanumanth Rao at vishnuh@mail.nih.gov. All offerors must maintain active SAM registration. Oxford Nanopore Technologies is located at 101 Avenue of the Americas, Floor 7, New York, New York 10013-1943.
Notice text
OXFORD NANOPRORE TECHNOLOGIES PROMETHOION 2 INTEGRATION LONG-READ SEQUENCER.
THIS PURCHASE IS FOR A PROMETHION 2 INTEGRATED LONG-READ SEQUENCER. THIS LONG READ SEQUENCING PROVIDES MORE INFORMATIVE READS THATN STANDARD NEXT-GENERATION SEQUENCING AND ALLOWS FOR BOTH WHOEL GENOME/TRANSCRIPTOME SEQUENCING AND BASE-CALL MODIFICATIONS AT THE SAME TIME. THIS PRODUCT ENABLES HIGH IMPACT AND REAL TIME MULTI OMICS INTEGRATION NOT FOUND IN OTHER SEQUENCING TECHNOLOGIES.
Files
| File | Type | Posted |
|---|---|---|
| NOTICE OF INTENT- OXFORD NANO TECHNOLOGIES LTD PCA NIAAA 08722.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| RNA sequencing and whole genome sequencing services | Office of Logisitics and Acquisition Operations | No set-aside | |
| DNA Sequencing Service | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - 4D-Nucleofector Core Unit and X Unit | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| Amplicon sequencing services | Office of Acquisitions and Grants | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity